Intensive Care Foundation Impact Survey
SWARM is coordinating the survey responses in the Peninsula region on behalf of RAFT.
The Intensive Care Foundation (ICF) is the research arm of the Intensive Care Society (ICS) and has been responsible for pump priming research studies in critical care in the UK that have led to national funding awards for larger definitive studies. This survey aims to assess the impact of major studies at the bedside. Researchers have a moral responsibility to make sure that trial funding is well spent and that resulting evidence can impact on patient care.
This is a point prevalence online survey of all patients in all participating Intensive Care Units in the United Kingdom. The study period will be a single day of choice between 6th March 2017 and 6th of April 2017 that the participating ICUs choose.
The impact of the seven studies to be evaluated are:
1. Beta-agonist in ALI (BALTI-2)
2. High frequency oscillation in ALI (OSCAR)
3. Simvastatin in ALI (HARP-2)
4. Vasopressin use in sepsis-related hypotension (VACS, VASST and VANSIH)
5. The use of old or young blood in transfusions in critically ill patients (ABLE)
6. The use of haloperidol for the prophylactic treatment of delirium (HOPE-ICU)
7. The timing of tracheostomy (TRACMAN).
The aim is that the results will be presented at the State of the Art Meeting 2017 and publication in a peer-reviewed journal.
Local Trust Project Leads